A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Open accessThe DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index; 20 of the 36 sources its claims cite were checked for support.
Abstract
Oncogene-induced senescence (OIS) is crucial for tumour suppression. Senescent cells implement a complex pro-inflammatory response termed the senescence-associated secretory phenotype (SASP). The SASP reinforces senescence, activates immune surveillance and paradoxically also has pro-tumorigenic properties. Here, we present evidence that the SASP can also induce paracrine senescence in normal cells both in culture and in human and mouse models of OIS in vivo. Coupling quantitative proteomics with small-molecule screens, we identified multiple SASP components mediating paracrine senescence, including TGF-β family ligands, VEGF, CCL2 and CCL20. Amongst them, TGF-β ligands play a major role by regulating p15(INK4b) and p21(CIP1). Expression of the SASP is controlled by inflammasome-mediated IL-1 signalling. The inflammasome and IL-1 signalling are activated in senescent cells and IL-1α expression can reproduce SASP activation, resulting in senescence. Our results demonstrate that the SASP can cause paracrine senescence and impact on tumour suppression and senescence in vivo.
Overview
CoChat Summary
## TL;DR
Cells undergoing oncogene-induced senescence (OIS) can transmit senescence to neighboring normal cells through secreted SASP factors, creating a stable paracrine senescence state in culture and in vivo. The paper identifies TGFβ family ligands and IL-1/inflammasome signaling as key regulators of this process.
## Key findings
- Normal IMR90 fibroblasts and HMECs became growth-arrested when co-cultured with OIS cells; the effect was transmitted through transwells and conditioned media, showing it was mediated by soluble factors rather than direct contact.
- Paracrine senescence resembled full senescence: normal cells showed increased DNA/oxidative damage, p16^INK4a^, p21^CIP1^, and SASP markers; gene-expression profiles of OIS and paracrine senescence were highly correlated and clustered together.
- Quantitative proteomics and a 78-compound screen implicated multiple SASP components in paracrine senescence, including TGFβ family ligands, VEGF, CCL2, and CCL20; blocking VEGFR2/FLT3, TGFBR1, or CCR2 partially impaired the arrest.
- The paper reports specific in vivo evidence of paracrine senescence: p21^CIP1^+/p16^INK4a^ cells were found near OIS lesions in mouse liver and skin, and in human serrated sessile adenomas the stromal p21^CIP1^/Ki-67^- signal was significantly increased near lesions (p = 0.03), with a separate comparison reporting p = 4.6 × 10^-5^ for p21^CIP1^ positive/Ki67 negative stromal cells.
## Methods
- Co-culture, transwell, conditioned-media, and cluster assays were used in human IMR90 fibroblasts and HMECs; OIS was induced with ER:RAS, MEK:ER, or related oncogenic constructs activated by 4OHT.
- Secretome analysis used SILAC-based quantitative proteomics, followed by a 78-compound receptor/pathway screen, RNAi knockdown, RT-qPCR, microarrays, GSEA, immunofluorescence/high-content analysis, and assays for BrdU, SA-β-Gal, caspase-1, and antibody arrays.
- In vivo validation used mouse OIS models including Nras-driven hepatocyte senescence, K5-Sos/Egfr^wa2/+^ skin papillomas, and Pdx1-Cre Kras^G12D^ pancreatic lesions, plus human SSA tissue IHC.
## Limitations
- The paper itself notes that “the nature of these cells and the functional implications of paracrine senescence remain open questions for future studies.”
- It also states that not all cells surrounding preneoplastic lesions undergo paracrine senescence; it proposes possible explanations such as soluble-factor gradients and cell-type susceptibility, but these are not experimentally resolved here.
- Evident from the text: many mechanistic and inhibitor results are partial (“partially rescued,” “partially prevented”), so the study does not identify a single exclusive mediator of paracrine senescence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Valid · 1 Not valid · 7 Not checked · 78 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“a transcriptional signature associated with senescence 18 was significantly upregulated during paracrine senescence (Fig 3d).”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > Paracrine senescence resembles a full senescence response
What the sources say
- Supportedcites [18] Fridman, A. L. & Tainsky, M. A. Critical pathways in cellular senescence and immortalization revealed by gene expression profiling. Oncogene27, 5975–5987 (2008). source
The 'Genomic approaches to identify senescence/immortalization genes and pathways' section describes gene-expression profiling that identifies genes and pathways associated with senescence. In the citing sentence, the citation identifies the senescence-associated transcriptional signature; the finding that it was significantly upregulated during paracrine senescence is attributed to the citing paper’s Fig. 3d, not to this source. No page number is available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Colon SSAs are mainly driven by activating BRAF mutations that trigger OIS 31,34,35 .”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > Paracrine senescence is observed in mouse and human models of OIS in vivo
What the sources say
- Partly supportedcites [31] Carragher, L. A. et al. V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a. EMBO Mol. Med.2, 458–471 (2010). sourceExperimental — accuracy not yet measured
The Discussion reports V600E BRAF mutations in approximately 70% of right-sided serrated hyperplastic polyps and serrated adenomas, supporting a major role for BRAF in the serrated pathway. The Results show that V600E Braf induces senescence in mouse small-intestinal crypts, but do not establish that BRAF mutations trigger OIS in human colon sessile serrated adenomas. (LLM, conf=0.87)
- Partly supportedcites [34] Kriegl, L. et al. Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancer. Mod. Pathol.24, 1015–1022 (2011). sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says that initiating BRAF mutations might drive oncogene-induced senescence in human serrated polyps, and concludes that the data provide evidence for senescence in the BRAF-mutated serrated route. It does not establish that colon sessile serrated adenomas are mainly driven by BRAF mutations: the study selected BRAF-mutated lesions for its final analysis, and its proposed causal link is hedged. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [35] Bennecke, M. et al. Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis. Cancer Cell18, 135–146 (2010). source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A signature derived from IMR90 cells undergoing paracrine senescence is found enriched in mouse PANIN 44 and human serrated sessile adenomas (SSA) 36 .”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > REFERENCES
What the sources say
- Partly supportedcites [44] Ling, J. et al. KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell21, 105–120 (2012). sourceExperimental — accuracy not yet measured
The Results section, “Inhibition of Key Proinflammatory Cytokines,” reports gene-expression profiles from mouse PanIN, so this paper provides the mouse PanIN data cited as reference 44. It does not report testing or finding enrichment of an IMR90 paracrine-senescence signature in those profiles. The SSA finding is attached to a different citation (36), not this source. (LLM, conf=0.79)
- Not checked — no full text of the sourcecites [36] Caruso, M. et al. Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis. Virchows Archiv.454, 291–302 (2009). source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we identified multiple SASP components mediating paracrine senescence, including TGF β family ligands, VEGF, CCL2 and CCL20.”
- Also stated in: § Abstract · plain
“Coupling quantitative proteomics with small molecule screens, we identified multiple SASP components mediating paracrine senescence, including TGF β family ligands, VEGF, CCL2 and CCL20.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Expression of the SASP is controlled by inflammasome-mediated IL-1 signalling.”
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
54 more claims
Create a free account to see all 101 claims and every source verdict.
- Probably not a substantial claim. 20
- It may state two separate claims as one. 21
- The quote only partly states this claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The senescent cell fate can be triggered by a number of stressors including DNA damage, cancerous mutations or oncogene activation, mitochondrial dysfunction, reactive metabolites, hyperoxia or hypoxia, proteotoxic stress, extracellular signals, infections, mechanical or shear stresses that deform cells, resistance exercise and factors secreted by other senescent cells18,38–47.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The inflammasome, a multiprotein complex comprising caspase 1 and key regulators of the defence mechanisms against pathogens117, and Toll-like receptors, which regulate the inflammasome, have been reported to promote maturation and secretion of SASP factors during OIS73,118.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, specific SASP components, either soluble or in extracellular vesicles186, can induce senescence in a paracrine manner — which includes DDR activation73,83.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Upstream signals triggering SASP activation are multiple and differ depending on the senescence inducer but include DNA damage, cytoplasmic chromatin fragments (CCFs) that trigger a type 1 interferon response, and damage-associated molecular patterns (DAMPs) that activate the inflammasome (Acosta et al., 2013; Davalos et al., 2013; Li and Chen, 2018).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Acosta et al., 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Higher secretion of SASP factors is also associated with an enhanced immune response, leading to inflammation which may promote tumorigenesis (Acosta et al., 2013).”
From Single senescent cell sequencing reveals heterogeneity in senescent cells induced by telomere erosion (2019) · cites this paper as Acosta et al., 2013
Experimental — accuracy not yet measured
47 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Self-citationPreinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Cited by
Items 1,801–1,900 of 2,273
Mallikarjun, V., Dobre, O., Jackson, M. R., Kidd, M., Llewellyn, J., Gilbert, H. T. J., Richardson, S. M., & Swift, J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.09.511462 · Cited by 3
Moore, M., Pardo, L., Mitchell, L. E., Schmidt, T., Waldron, J. A., May, S., Müller, M., Smith, R. C. L., Strathdee, D., Bryson, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.16.553544 · Cited by 2
“Human lung fibroblasts, IMR90-ER:RAS cells (IMR90s) expressing a chimeric fusion protein that activates upon treatment with 4-hydroxytamoxifen (4OHT) were a kind gift from Juan Carlos Acosta, University of Cantabria, Spain, and are described in 42 .”
MethodSelf-citationZhu, Y., Xiang, M., Brulois, K., Lazarus, N. H., Pan, J., & Butcher, E. C. (2024) · Research Square · doi:10.21203/rs.3.rs-4538031/v1 · Cited by 6
“The other members, including TGFβ2 and BMP2, have also been implicated in fibroblast functions in other disease settings 68,69 and may contribute to EC modulation of CAFs.”
BackgroundEpigenetic Disordering Drives Stemness, Senescence Escape and Tumor HeterogeneityPreprint
Magnani, E., Macchi, F., Randic, T., Chen, C., Madakashira, B. P., Ranjan, S., Eski, S. E., Singh, S. P., & Sadler, K. C. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.29.629346 · Cited by 4
The role of senescence in polymyalgia rheumatica and giant cell arteritis
Alegria, G. C. (2025) · Joint Bone Spine · doi:10.1016/j.jbspin.2025.105860 · Cited by 2
The rise of RAS: how gradual oncogene activation shapes the OIS spectrum
Zhu, H., Chan, A. S. L., & Narita, M. (2025) · Genes & Development · doi:10.1101/gad.352761.125 · Cited by 4
“For example, SASP factors can promote senescence in adjacent cells via amplifying inflammatory signaling (Acosta et al. 2008, 2013; Kuilman et al. 2008).”
Senescent cells exhibit features of developmental signaling centresPreprint
Gonçalves, D. S., Dulac, L., Ritschka, B., Rhinn, M., Klein, A., Wyatt, C. D. R., Irimia, M., & Keyes, W. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.30.685565 · Cited by 2
“Some of these factors have already been associated with cellular senescence and the SASP in specific contexts, including some BMPs, Wnts, IGFBPs and others 26–28 .”
Bertoli, G., Phadke, K., Cospito, A., Rizk, J. A., Zhang, M., Miliotou, E., Cammer, M., Deng, Y., Mezzano, V., Alu, M., et al. (2025) · doi:10.1101/2025.10.22.682160 · Cited by 2
Jang, D., Shim, E., Shin, J., Kim, S., Ciotlos, S., Kim, H. J., Gil, T., Kim, Y., & Jeon, O. H. (2026) · Aging Cell · doi:10.1111/acel.70540 · Cited by 2
“Primary SnCs are induced directly by intrinsic stressors, such as DNA damage, whereas secondary SnCs arise through paracrine (Acosta et al. 2013; Nelson et al. 2012) or systemic signaling mechanisms driven by SASP factors released by primary SnCs (Jeon et al. 2022).”
González-Meljem, J. M., Haston, S., Gallage, S., & Innes, A. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-95387-8_3 · Cited by 1
Lee, J., Lee, S., Kim, K., Park, K., & Park, K. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1137-9 · Cited by 2
Targeting the secretory program of 3q-amplified lung cancers
Pardo, L., & Norman, J. C. (2024) · Journal of Clinical Investigation · doi:10.1172/jci181798 · Cited by 1
“The SASP can be driven by upregulated MAPK signaling following acquisition of activating mutations in proto-oncogenes such as Ras and Raf and by other potentially carcinogenic events such as genetic instability (8).”
BackgroundSenescence Signatures Predict Hospitalization Risk and Severity in COVID-19 Patients
Singh, T., Lynch, S. M., McLarnon, T., Cooper, E., McDaid, D., Guo, G., McLaughlin, J. K., McGilligan, V., Watterson, S., Shukla, P., et al. (2024) · doi:10.59368/agingbio.20240035 · Cited by 1
“…the exacerbation of the senescence-associated secretory phenotype (SASP) and is characterized by the secretion of a plethora of pro-in fl ammatory cytokines and chemokines, including extracellular matrix-modi-fying, complement-activating, and procoagulatory factors by senescent cells 18,23,25 – 27 .”
BackgroundInducing Cellular Senescence in Mouse Embryonic Fibroblasts (MEFs)
Lorandi, I., & Li, H. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-4128-6_17 · Cited by 1
Zubiaur, M., Terron-Camero, L. C., Gordillo-González, F., Andrés‐León, E., Jesús, A. B.-D., Canet-Antequera, L. M., Sánchez‐Cañete, M. P., Martínez-Blanco, Á., Domínguez-Pantoja, M., Botía-Sánchez, M., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1441981 · Cited by 1
Song, X., Zhu, H., Zhang, J., Wang, D., Hu, S., & Wang, B. (2025) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162024605329 · Cited by 2
Radiation-induced senescent melanoma cells secrete soluble factors that trigger bystander senescence
Salvarredi, L. A., Agüero, H., Millán, M., Marra, M. F., Callegari, E. A., Castro, C., & Lopez, L. (2025) · International Journal of Radiation Biology · doi:10.1080/09553002.2025.2505525 · Cited by 2
“This finding appears to be at odds with previous reports suggesting that the SASP induces senescence in fibroblasts (Acosta et al. 2013).”
Cortés, S. Á., Paula‐Manuela, R. Z., & Vernot, J. (2025) · Journal of Cell Communication and Signaling · doi:10.1002/ccs3.70009 · Cited by 3
“SASP is responsible in part of the senescence effects in the tumor microenvironment, 49,50 and transient exposure to the SASP can promote cell plasticity and tissue regeneration of cancer cells.”
Ferreira, R. S., Aires, H. I. R., Rebelo, C., Passos, J. F., Ori, A., Pitrez, P. R., & Ferreira, L. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124117 · Cited by 3
Balancing senescence and apoptosis: therapeutic insights into aging and cancer
Jan, N., Sofi, S., Mir, A. A., Masoodi, G., & Mir, M. A. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05355-3 · Cited by 4
“This is primarily accomplished by IL-1A and TGF-β mediating signaling in both cell culture and in vivo models of oncogene-induced senescence [34].”
InfluentialDown-regulation of IGFBP2 mediates endometrial epithelial cells senescence in thin endometrium
Zhou, Z., Zhou, Z., Ye, C., Li, N., Zhu, Y., Ma, P., Wu, J., Hu, Y., Sun, H., & Zhao, G. (2025) · Molecular Human Reproduction · doi:10.1093/molehr/gaaf032 · Cited by 2
Li, M., Du, J., Wang, G., Feng, W., Chen, J., & Zhang, C. (2025) · Discover Oncology · doi:10.1007/s12672-025-02935-z · Cited by 1
“On the other hand, weakened immunity induced by tumor also leads to a significant attenuate ability of SASP for subsequent scheduling immune system, thus accelerating the deterioration of TME [11].”
Exploring the uncharted role of cell senescence in rare diseases
Selvaggio, P., Taci, E., Barassi, A., Massa, V., Gervasini, C., Lesma, E. A., Bernardelli, C., & Fede, E. D. (2025) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-025-03778-1 · Cited by 1
“All SASP factors have autocrine and paracrine activity and are involved in extracellular matrix (ECM) remodeling, immunosurveillance and senescence propagation (bystander effect) [11, 27].”
Patel, M., Kumar, S., Dugam, P., Singh, A., & Yadav, P. N. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00041 · Cited by 2
From Lasers to Longevity: Exploring Energy-Based Devices as Senotherapeutic Tools in Dermatology
Hrițcu, O. M. C., Costan, V. V., Toader, Ș. V., Branisteanu, D. E., & Toader, M. P. (2025) · Cosmetics · doi:10.3390/cosmetics12050201 · Cited by 1
Research progress on cell cycle arrest in dermal fibroblasts
Wu, M., Luo, J., Yang, W., Wei, Z., Li, Y., & Pan, X. (2025) · Cell Cycle · doi:10.1080/15384101.2025.2557240 · Cited by 1
“Senescent fibroblasts activate the NF-κB signaling pathway by secreting SASP factors, such as IL-6 and IL-8, thereby recruiting neutrophils and macrophages to amplify localized inflammation [72].”
Han, D. D., Brooks, A. C., Baker, C. D., Dirkx, R. A., Mickelsen, D. M., Fisler, B., Phadke, K., Ashton, J. M., Delmar, M., & Small, E. M. (2026) · Circulation Heart Failure · doi:10.1161/circheartfailure.125.013966 · Cited by 1
Ding, C., Ge, H., Yang, X., Zhang, Y., Yang, G., Zhang, L., Li, S., Zhong, H., Ma, J., Cai, Z., et al. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202509165 · Cited by 1
Deinhardt-Emmer, S., Trottein, F., Armando, F., Tolosa, R. M., Rodríguez-Agustín, A., Casanova, V., Climent, N., Martínez-Orellana, P., Scarpa, E., Gariglio, M., et al. (2025) · Aging · doi:10.18632/aging.206349 · Cited by 1
“Notably, they found that senescence from infected cells resulted transmissible to neighboring uninfected cells via paracrine SASP factors [30].”
Bartolucci, M., Utyro, O., Muraglia, A., Repetto, A., Agostini, V. W., Pizzonia, M., Ottaviani, S., Tripodi, G., Filaci, G., Cancedda, R., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1695213 · Cited by 1
Cellular senescence in lung cancer immune microenvironment and senotherapeutic opportunities
Xu, Z., Liu, F., Huang, S., & Chu, Q. (2026) · iScience · doi:10.1016/j.isci.2026.114673 · Cited by 4
“21,47 In lung cancer, these pathways are exemplified by CCL2-CCR2-driven MDSC accumulation in NSCLC patients and mouse models and by TIS upregulating PD-L1 on tumor cells.”
Pyrimidine-based compounds as promising anticancer agents targeting tumor cell senescence
Carpintero-Fernández, P., Martínez, M. M., Carneiro-Figueira, A., Martínez, R., García-Yuste, A., Barturen-Gómez, M., Pérez-Caaveiro, C., Guitián‐Caamaño, A., Sarandeses, L. A., Sestelo, J. P., et al. (2026) · Molecular Therapy Oncology · doi:10.1016/j.omton.2026.201129 · Cited by 2
Gushchevarov, D. A., Ermakov, I., Datskevich, P. N., Rozov, F. N., Filatov, V. L., Postnikov, A. B., & Serebryanaya, D. V. (2025) · Neurochemical Journal · doi:10.1134/s1819712425700771 · Cited by 1
Wei, Z., Li, Z., & Quan, N. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1702207 · Cited by 1
Astrocyte Senescence Impairs Synaptogenesis due to Thrombospondin‐1 Loss
Ercoli, S., Casares-Crespo, L., Juárez‐Escoto, E., & Mira, H. (2026) · Aging Cell · doi:10.1111/acel.70382 · Cited by 2
“…proteasome inhibition, DNA damage, and alterations in cellular communication systems, due to paracrine signals released by neighboring senescent cells (Takai et al. 2003; Torres et al. 2006; Pricola et al. 2009; Bitto et al. 2010; Rodier et al. 2011; Acosta et al. 2013; Clevers and Watt 2018).”
A Novel Human Cellular System for Studying Normal Aging and for Anti‐Aging Discovery
Feng, Z., Li, C. S., Fu, H., Jiang, W., Zhang, W., Huang, Y., Huang, Y., Tam, T. T. K. K., Li, Y., Liu, F., et al. (2026) · Aging Cell · doi:10.1111/acel.70352 · Cited by 1
“The SASPs propagate senescence to neighboring cells, inducing “inflammaging” and accelerating tissue dysfunction and organ aging (Acosta et al. 2013; Moiseeva et al. 2023).”
Yu, K., Chen, M., Hou, W., Lu, J., Liu, Q., Zeng, W., Du, Z., Hou, X., Hao, E., Deng, J., et al. (2026) · Human Mutation · doi:10.1155/humu/1465989 · Cited by 1
Proteomic profiling and regenerative potential of bovine placental extract in wound healing models
Ospina, J. A. G., Martinez, E. M. M., Sampa, S. H., et al. (2026) · Journal of Advanced Pharmaceutical Technology amp Research · doi:10.4103/japtr.japtr_157_25 · Cited by 1
Liver senescence in focus: Heterogeneity across aging and cancer
Bishop, C. L. (2026) · Cell Genomics · doi:10.1016/j.xgen.2026.101168 · Cited by 1
Gausepohl, T., Pfeffer, T. J., König, T., et al. (2026) · ESC Heart Failure · doi:10.1093/eschf/xvag062 · Cited by 1
Multidimensional mechanisms of quercetin in diabetic kidney disease
Gong, Z., Che, Q., Wang, C., Liu, B., Hu, M., Zhang, H. P., Liang, N., Li, H., Zhao, G., Yan, L., et al. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1705601 · Cited by 3
Bartolocci, V., Capone, A., Monetta, R., et al. (2026) · Journal of Biomedical Science · doi:10.1186/s12929-026-01227-0 · Cited by 1
“Thus, the ANA-12 secretome exhibits a SASP profile that favors immune recruitment and tissue remodeling instead of overt inflammatory cytotoxicity [68, 99].”
Chondrocyte Senescence in Osteoarthritis: Potential Targets and Pharmacological Interventions
Tan, D. Y., Guo, J., Wang, T., Yang, S., Liu, J., Wang, D., & Li, W. (2026) · Cartilage · doi:10.1177/19476035251414314 · Cited by 3
“31,32 Pro-inflammatory cytokines, including IL-1 β and TNF-α , exacerbate this cycle by disrupting mitochondrial function in human chondrocytes.”
Adipocytes as core drivers of skin aging and novel targets for regeneration
Wang, E., Xu, Z., Wang, Y., Wang, J., Jiang, Y., & Zhao, C. (2026) · Biogerontology · doi:10.1007/s10522-026-10413-4 · Cited by 2
“In the dermis, SASP-associated cytokines/chemokines can promote matrix-remodeling programs such as MMP induction in dermal fibroblasts (Nelson et al. 2012; Acosta et al. 2013; Teo et al. 2019).”
Integrative Approaches to Treating Cellular Senescence in Kidney Disease
Misawa, T., Amruta, A., Hickson, L. J., & Wolfram, J. (2026) · Advanced Science · doi:10.1002/advs.202519392 · Cited by 1
Epigenetic dynamics of cellular senescence: From mechanistic insights to precision senotherapy
Hu, X., Lai, W., Liu, M., & Wang, B. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004042 · Cited by 2
“[65] It is this rich secretome of the SASP that allows SnCs to exert beneficial or detrimental effects in diverse patho-physiological contexts, serving as a “double-edged sword” that appears to be time-and context-dependent.”
Inflammaging and oral diseases: New sights from pathology to therapeutic consideration
Yang, T., Liu, D., & Hu, M. (2026) · Translational dental research. · doi:10.1016/j.tdr.2026.100079 · Cited by 3
Oku, K. (2026) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.70820 · Cited by 1
“These fibroblasts secrete various pro-inflammatory cytokines and growth factors, collectively known as the senescence-associated secretory phenotype (SASP), exacerbating the condition by sustaining chronic inflammation and disrupting dermal–epidermal homeostasis [5].”
The Biological Mechanisms of Frailty: Focusing on Cellular Senescence
Erusalimsky, J. D. (2026) · European Cardiology Review · doi:10.15420/ecr.2025.81 · Cited by 1
“82,83 This cascade phenomenon explains how relatively small populations of senescent cells may contribute significantly to the chronic, low-grade inflammation that develops with advancing age (coined ‘inflammageing’), and the multisystem physiological decline characteristic of frailty.”
Liu, Y., Ji, D., Lin, Y., Ye, S., Guo, R., Luo, Z., & Xiao, F. (2026) · Environmental Pollution · doi:10.1016/j.envpol.2026.128062 · Cited by 1
Wu, J., Li, M., Shi, Y., & Wang, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1807871 · Cited by 3
Spliceosome induction is a druggable dependency of RAS-driven senescence and cancer
Wagner, V., Bousset, L., Ascensão-Ferreira, M., Sun, B., Avila, J. E. B., Kaizeler, A., Martins-Silva, R., Rahbari, M., Fernández-Vaquero, M., Haston, S., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71564-z · Cited by 3
“Treatment of these cells with 4-hydroxy-tamoxifen (4OHT) activates RAS, triggering senescence 32,33 , while similar treat-ment has no effect in control IMR90 cells infected with an empty vector(SupplementaryFig.1).”
Self-citationMechanistic advances and emerging technologies redefining lung aging research
Wheeler, L. F., Lehmann, M., & Melo-Narváez, M. C. (2026) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00912.2025 · Cited by 1
Fava, V. M., Dallmann-Sauer, M., Orlova, M., Correa-Macedo, W., Olivenstein, R., Costiniuk, C. T., Routy, J., Barreiro, L. B., & Schurr, E. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1805936 · Cited by 1
Yılmaz, V. (2026) · Genes · doi:10.3390/genes17050527 · Cited by 1
“…cells, particularly in fibroblast systems where IL-1 α is often described as a proximal SASP trigger, both cytokines converge on shared receptor-proximal signaling components and NF-κ B activation, supporting pathway-level analyses of IL-1 signaling in the context of senescence [9,10,12–14].”
Cellular senescence: from pathogenic mechanisms to precision anti-aging interventions
Deng, J., Sun, R., Bai, Z., Fang, L., Zhao, X., & Yang, D. (2026) · Aging · doi:10.18632/aging.206375 · Cited by 2
“By secreting a potent cocktail of proinflammatory and profibrotic cytokines, alongside the dysregulated expression of MMPs, senescent macrophages fundamentally destabilize the renal microenvironmental rheostat [96].”
Singh, D., & Bhattacharya, S. (2026) · Therapeutic Delivery · doi:10.1080/20415990.2026.2668850 · Cited by 3
Jin, C., Liu, H., Wu, Z., Hu, Y., Cui, Y., Guo, R., & Li, H. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1830436 · Cited by 1
Manni, E., Al‐kuraishy, H. M., Shokr, M. M., & Batiha, G. E. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01874-0 · Cited by 4
“…proteins (C/EBP), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), mTOR, and Janus kinase-signal transducer and activator of transcription (JAK/STAT) signaling (Table 1)(Goehe et al. 2012; Acosta et al. 2013; Alspach et al. 2014; Toso et al. 2014; Laberge et al. 2015).”
Yang, J., Zhao, J., Li, Z., Tian, Z., Wu, Y., Lian, H., Li, H., Chen, S., Li, C., & Guo, Z. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.177769 · Cited by 1
From systemic disease to the eye: Why senescence deserves attention in ocular infections
Maiti, S., & Joseph, J. (2026) · Experimental Eye Research · doi:10.1016/j.exer.2026.111095 · Cited by 1
Pyroptosis in Ovarian Aging, and Its Influence on Female Reproductive Health in Aged Ovaries
Berkel, Ç. (2026) · American Journal of Reproductive Immunology · doi:10.1111/aji.70265 · Cited by 1
Immunological consequences of senescence in physiology and pathology
Zubova, A., Pietrocola, F., & Morsli, S. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08335-3 · Cited by 7
“In murine models of OIS, inflammasome activation shapes the secretory programme by promoting cytokine maturation and reinforcing paracrine senescence [24].”
p16 Beyond Senescence: Cancer Biology Lessons Applied to Endometriosis
Kobayashi, H. (2026) · Reproductive Sciences · doi:10.1007/s43032-026-02134-3 · Cited by 1
“SASP exerts cell-nonautonomous effects on surround - ing normal cells, premalignant cells, immune cells, and stromal cells, contributing to immune cell recruitment, clearance of senescent cells, propagation of senescence, and tissue remodeling [13, 16, 22, 24, 28, 29].”
Targeting the senescence‒autophagy axis via p16INK4a inhibition alleviates pulmonary fibrosis
Yoo, Y. J., Zhang, M., Jin, S.-H., Lee, Y. R., Jin, H., Doan, T.-P., Kim, S., Choi, S., Park, E., Na, S., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02730-4 · Cited by 3
Self-citationSenescence in non-cancerous cells within the tumor: What is the real deal?
Perramon‐Güell, A., & Anerillas, C. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189654 · Cited by 1
Wei, R., Liu, D., Shu, K., & Zhu, H. (2026) · Drug Resistance Updates · doi:10.1016/j.drup.2026.101444 · Cited by 3
Yao, M., Liu, A., Xing, L., Song, J., Yang, Y., Yue, X., & Li, H. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103260 · Cited by 1
Cellular senescence and inflammageing: from mechanisms to senotherapeutic interventions
Chmielewski, P. P. (2026) · Biogerontology · doi:10.1007/s10522-026-10477-2 · Cited by 3
“…(GFs), proteases and extracellular matrix (ECM) remodelling molecules that disrupt tissue homeostasis, propagate secondary senescence via paracrine signalling and modulate local immune function (Coppé et al. 2010; Nelson et al. 2012; Acosta et al. 2013; da Silva et al. 2019; Wang et al. 2024a, b).”
CXCR4-targeted dual softener for inducing senescence therapy in hepatic fibrosis
Mu, J., Dong, J., Chen, J., Sima, P., Fan, Y., Gong, X., Zhou, J., Yang, X., Zhou, Z., & Sun, M. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2600215123 · Cited by 1
Immune surveillance and immune evasion of senescent cells
Garcia-Baucells, P., Serrano, M., & Amor, C. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01335-w · Cited by 5
The telomeric DNA damage response as a therapeutic target in idiopathic pulmonary fibrosis
Rossiello, F., Cicio, G., Sepe, S., Mancheno-Ferris, A., Cancila, V., Castellini, A., Rey, F., Bertolazzi, G., Oppezzo, A., Marinelli, E., et al. (2026) · EMBO Molecular Medicine · doi:10.1038/s44321-026-00500-x · Cited by 3
“…tDDR inhibition in primary senescent cells prevents the spread of secondary senescence due to paracrine and juxtacrine signaling (Admasu et al, 2021), may further contribute to the reduction of the number of γ H2AX-positive cells (Nelson et al, 2012; Acosta et al, 2013; Victorelli et al, 2019).”
A causal role of ATM- and NEMO-dependent NF-κB activation in DNA damage-induced senescence and aging
Zhao, J. (2016) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 3
mTOR, Aging, and Cancer: A Dangerous Link
Sharp, Z. D., & Hasty, P. (2015) · Springer eBooks · doi:10.1007/978-2-8178-0492-7_13 · Cited by 3
Chromatin Signaling in Aging and Cellular Senescence
Couteau, F., & Mallette, F. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802389-1.00016-2 · Cited by 1
The Interplay Between Inflammatory Signaling and Nuclear Structure and Function
Hubáčková, S., Moravcová, S., & Hodný, Z. (2016) · Springer eBooks · doi:10.1007/978-3-319-38882-3_12 · Cited by 1
Aging and stability of cardiomyocytes
Chakravarty, S., Rajasingh, J., & Ramalingam, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820071-1.00020-7 · Cited by 1
Characteristics of senescent cells
Schmitt, R., & Melk, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823318-4.00035-4 · Cited by 1
Hydrogen Sulfide and the Kidney
Kasinath, B. S., & Lee, H. J. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-16-0991-6_2 · Cited by 2
Immunesenescence and Compromised Removal of Senescent Cells: Implications for Health in Old Age
Hazeldine, J., & Lord, J. M. (2021) · Healthy ageing and longevity · doi:10.1007/978-3-030-87532-9_3 · Cited by 1
Liver diseases fibrosis and cirrhosis
Bird, T. G., & Kiourtis, C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00004-3 · Cited by 1
González‐Gualda, E., Ou, H., Macías, D., & Muñoz‐Espín, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00016-x · Cited by 2
Thompson, P. J., & Bhushan, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00008-0 · Cited by 1
Capri, M., Franceschi, C., & Salvioli, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11283-8 · Cited by 3
Lautrup, S., Anisimov, A. S., Lagartos-Donate, M. J., & Fang, E. F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91617-2.00010-9 · Cited by 4
Methods for detection of mitochondrial reactive oxygen species in senescent cells
Fenniche, S., Oubaddou, Y., Bakri, Y., Dupuy, C., & Hassani, R. A. E. (2022) · Methods in cell biology · doi:10.1016/bs.mcb.2022.09.011 · Cited by 2
The role of cellular lipid metabolism in aging
Chen, X., & Liu, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95582-9.00013-9 · Cited by 3
Palmer, A. K., & Kirkland, J. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15500-0.00012-8 · Cited by 2
Non-ionizing radiation-induced cellular senescence and age-related diseases
Wang, H., Tong, J., & Cao, Y. (2024) · Radiation Medicine and Protection · doi:10.1016/j.radmp.2024.04.002 · Cited by 5
Bai, S.-R., Zhao, Q., Jia, H., He, F., & Wang, X. (2024) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2023-0432 · Cited by 2
Wang, W., Chen, Y., Shen, Y., Chen, J., Yao, X., Cheng, Y., Xu, J., Ma, L., Chen, Y., & Zhang, C. (2024) · Rejuvenation Research · doi:10.1089/rej.2024.0008 · Cited by 1
NF-kB oscillation profiles decode response to anti-EGFR monoclonal antibodies
Romaniello, D., Dall'Olio, L., Mazzeschi, M., et al. (2025) · SLAS DISCOVERY · doi:10.1016/j.slasd.2025.100219 · Cited by 1
Pancreatic β-Cell Senescence: A Contributor to Type 2 Diabetes
Urmi, R., Singh, R., Singh, M., & Sinha, B. K. (2025) · Springer eBooks · doi:10.1007/978-981-96-1041-9_8 · Cited by 1
Studying Cellular Senescence Using the Model Organism Drosophila melanogaster
Louka, X. P., Gumeni, S., & Trougakos, I. P. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4426-3_17 · Cited by 3
James, E. L., Teh, M., Li, Y., Wagner-Bock, C., Al-Khateeb, Z. F., Karen‐Ng, L. P., Roberts, T., Synchyshyn, L., Lewis, A. L., O’Loghlen, A., et al. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1583288 · Cited by 4
Zhang, Y., Yan, Y., Wang, J., & Liu, J. (2025) · Discover Oncology · doi:10.1007/s12672-025-03142-6 · Cited by 1
“Current research suggests that senescent cancer cells could use the SASP produced to activate the immune system, thereby killing cancer cells and inhibiting cancer cell development and migration [33, 34].”
Childs, M., Passel, T., Tamagnini, F., Cottrell, G. S., Iandolo, D., & Widera, D. (2025) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2025.102786 · Cited by 1
Aging and Cardiovascular Diseases: The Role of Cellular Senescence
Bozaykut, P. (2019) · Springer eBooks · doi:10.1007/978-981-13-8273-4_10 · Cited by 3
Fine-tuning of Rat Mesenchymal Stem Cell Senescence via Microtopography of Polymeric Substrates
Xu, X., Wang, W., Nie, Y. G., Kratz, K. L., Ma, N., & Lendlein, A. (2020) · MRS Advances · doi:10.1557/adv.2019.446 · Cited by 1
Integrating Context of Tumor Biology and Vaccine Design to Shape Multidimensional Immunotherapies
Wang, N. S., & Maine, C. J. (2020) · Future Drug Discovery · doi:10.4155/fdd-2019-0031 · Cited by 1
Metadata
- Authors
- Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., Pascual, G., Morris, K. J., Khan, S., Jin, H., Dharmalingam, G., Snijders, A. P., Carroll, T., Capper, D., Pritchard, C., Inman, G. J., Longerich, T., Sansom, O. J., Benitah, S. A., Zender, L., & Gil, J.
- Affiliations
- Imperial College London (GB)
- Centre for Genomic Regulation (ES)
- Cancer Research UK Scotland Institute (GB)
- University of Tübingen (DE)
- German Cancer Research Center (DE)
- University of Leicester (GB)
- University of Dundee (GB)
- Corresponding author
- Gil, Jesús
- ORCID
- Acosta, Juan Carlos
- Banito, Ana
- Janich, Peggy
- Morton, Jennifer P.
- Athineos, Dimitris
- Lasitschka, Felix
- Andrulis, Mindaugas
- Pascual, Gloria
- Khan, Sadaf
- Jin, Hong
- Snijders, Ambrosius P.
- Carroll, Thomas
- Capper, David
- Pritchard, Catrin
- Inman, Gareth J.
- Longerich, Thomas
- Sansom, Owen J.
- Benitah, Salvador Aznar
- Zender, Lars
- Gil, Jesús
- Venue
- Nature Cell Biology
- Published
- 2013-06-16
- Volume
- 15
- Issue
- 8
- Pages
- 978-990
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC3732483
- OpenAlex
- W2140930678
- Semantic Scholar
- 59786bed7ce43f9317328cd82838f14d911e5dd4
- Cited by
- 2,278
- References
- 54
- Citations by year
- 2026: 247 · 2025: 225 · 2024: 232 · 2023: 240 · 2022: 264 · 2021: 250 · 2020: 202 · 2019: 154 · 2018: 119 · 2017: 107 · 2016: 89 · 2015: 79 · 2014: 56 · 2013: 13
- FWCI
- 54.88
- Type
- journal article
- Language
- en
- Update notices
- correction (2026-04-28)
- Open access
- green
- europepmc.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- NERC Open Research Archive (Natural Environment Research Council) (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (acceptedVersion, other-oa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Cancer Research UK (A7769, 13083, 11650, 12481)
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- oncogene-induced senescence, senescence-associated secretory phenotype, paracrine senescence, inflammasome, IL-1 signaling, TGF-beta ligands, vascular endothelial growth factor, MCP-1, CCL20, CDKN2B, p21, tumor suppression, senescence-associated secretome
- MeSH terms
- Animals, Colonic Neoplasms, Humans, Immunohistochemistry, Interleukin-1, Protein Binding, Signal Transduction, Gene Expression Regulation, Neoplastic, Cellular Senescence, Paracrine Communication, Models, Animal, Cell Line, Tumor, Mice, Transforming Growth Factor beta1, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.